These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21170436)

  • 21. The therapeutic potential of modulators of the Hedgehog-Gli signaling pathway.
    Stecca B; Ruiz i Altaba A
    J Biol; 2002 Nov; 1(2):9. PubMed ID: 12437768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Novel GANT61 Analogs with Activity in Hedgehog Functional Assays and GLI1-Dependent Cancer Cells.
    Abu Rabe D; Chdid L; Lamson DR; Laudeman CP; Tarpley M; Elsayed N; Smith GR; Zheng W; Dixon MS; Williams KP
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient Synthesis of Heterocyclic Flavonoids with Hedgehog Signal Inhibitory Activity.
    Arai MA; Utsumi T; Yanase N; Fujimatsu T; Ishibashi M
    Chem Pharm Bull (Tokyo); 2017; 65(8):784-795. PubMed ID: 28768932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Gli/hedgehog signaling in prostate cancer cells by "cancer bush" Sutherlandia frutescens extract.
    Lin H; Jackson GA; Lu Y; Drenkhahn SK; Brownstein KJ; Starkey NJ; Lamberson WR; Fritsche KL; Mossine VV; Besch-Williford CL; Folk WR; Zhang Y; Lubahn DB
    Cell Biol Int; 2016 Feb; 40(2):131-42. PubMed ID: 26377232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma.
    Mori Y; Okumura T; Tsunoda S; Sakai Y; Shimada Y
    Oncology; 2006; 70(5):378-89. PubMed ID: 17179732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CBC-1 as a Cynanbungeigenin C derivative inhibits the growth of colorectal cancer through targeting Hedgehog pathway component GLI 1.
    Chen J; Chen W; Li X; Ye Y; Huang W; Gao L; Zhang M
    Steroids; 2024 Jun; 206():109421. PubMed ID: 38614233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting GLI proteins in human cancer by small molecules (WO2014116651 A1): a patent evaluation.
    Hadden MK
    Expert Opin Ther Pat; 2015 May; 25(5):613-7. PubMed ID: 25772316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phorbol esters inhibit the Hedgehog signalling pathway downstream of Suppressor of Fused, but upstream of Gli.
    Lauth M; Bergström A; Toftgård R
    Oncogene; 2007 Aug; 26(35):5163-8. PubMed ID: 17310984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer cells.
    Maeda O; Kondo M; Fujita T; Usami N; Fukui T; Shimokata K; Ando T; Goto H; Sekido Y
    Oncol Rep; 2006 Jul; 16(1):91-6. PubMed ID: 16786128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain as a paradigm of organ growth: Hedgehog-Gli signaling in neural stem cells and brain tumors.
    Stecca B; Ruiz i Altaba A
    J Neurobiol; 2005 Sep; 64(4):476-90. PubMed ID: 16041742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression profiling identifies novel Hh/Gli-regulated genes in developing zebrafish embryos.
    Bergeron SA; Milla LA; Villegas R; Shen MC; Burgess SM; Allende ML; Karlstrom RO; Palma V
    Genomics; 2008 Feb; 91(2):165-77. PubMed ID: 18055165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?
    Ruiz i Altaba A
    Cancer Cell; 2008 Oct; 14(4):281-3. PubMed ID: 18835029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gli code: an information nexus regulating cell fate, stemness and cancer.
    Ruiz i Altaba A; Mas C; Stecca B
    Trends Cell Biol; 2007 Sep; 17(9):438-47. PubMed ID: 17845852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor TAK-441 for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice.
    Kogame A; Tagawa Y; Shibata S; Tojo H; Miyamoto M; Tohyama K; Kondo T; Prakash S; Shyu WC; Asahi S
    Drug Metab Dispos; 2013 Apr; 41(4):727-34. PubMed ID: 23298863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
    Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
    Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer.
    Sanchez P; Clement V; Ruiz i Altaba A
    Cancer Res; 2005 Apr; 65(8):2990-2. PubMed ID: 15833820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hedgehog--Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer.
    Ruiz i Altaba A; Stecca B; Sánchez P
    Cancer Lett; 2004 Feb; 204(2):145-57. PubMed ID: 15013214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonclassical hedgehog-GLI signaling and its clinical implications.
    Shevde LA; Samant RS
    Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gli genes in development and cancer.
    Matise MP; Joyner AL
    Oncogene; 1999 Dec; 18(55):7852-9. PubMed ID: 10630638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.